|
Market Closed -
Deutsche Boerse AG
11:34:05 20/08/2026 am IST
|
5-day change | 1st Jan Change | ||
| 14.36 EUR | +5.28% |
|
+12.89% | +173.78% |
| 03/07 | Genfit soars on news of U.S. reimbursement for a product |  |
| 03/07 | Genfit's Liver Disease Blood Test Approved for US Medicare Reimbursement | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 5.05TCr | |||||
| 4.6TCr | - | - | - | - | - |
| 4.28TCr | |||||
| 4.1TCr | |||||
| 3.2TCr |
- Stock Market
- Stocks
- GNFT Stock
- XUP Stock
- Charts GENFIT
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
